FIELD: medicine; pharmacology.
SUBSTANCE: invention is related to endonasal application of heptapeptide metyonil-glutamyl-histidil-phenylalanil-prolyl-glycil-proline in concentration of 0.1% solution as additional medication in complex therapy of atopic dermatitis with lichenification.
EFFECT: reduction of treatment time and increase of remission duration and depth.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING PSORIASIS | 2006 |
|
RU2322255C1 |
| METHOD OF TREATING ATOPIC DERMATITIS | 2011 |
|
RU2468835C1 |
| METHOD OF ALLERGIC DERMATITIS TREATMENT | 2008 |
|
RU2365392C1 |
| WAY OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2361604C1 |
| METHOD FOR PREDICTING THE FLOW OF ATOPIC DERMATITIS | 2005 |
|
RU2310195C2 |
| METHOD FOR EVALUATING THE EFFICIENCY IN TREATING ATOPIC DERMATITIS IN CHILDREN | 2006 |
|
RU2317777C1 |
| METHOD OF ATOPIC DERMATITIS TREATMENT | 2006 |
|
RU2329837C2 |
| METHOD FOR PREDICTING SEVERITY OF ATOPIC DERMATITIS IN CHILDREN WITH ACCOMPANYING INTESTINAL DYSBACTERIOSIS | 2018 |
|
RU2692803C1 |
| METHOD FOR COMPLEX EXPOSURE ON NEURAL-REFLEX ITCHING MECHANISMS IN PATIENTS WITH ATOPIC DERMATITIS | 2013 |
|
RU2523634C1 |
| METHOD FOR TREATING ATOPIC DERMATITIS | 2002 |
|
RU2248804C2 |
